BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1615681)

  • 1. [Differentiated therapy of the climacteric syndrome].
    Huber J
    Wien Med Wochenschr; 1992; 142(5-6):124-6. PubMed ID: 1615681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estrogen substitution therapy in climacteric: should progesterone be omitted in hysterectomized women?].
    Huber J
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):257-61. PubMed ID: 1860657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone replacement therapy in the climacteric: benefits beyond sexuality.
    Maia H; Casoy J; Valente J
    Gynecol Endocrinol; 2009 Jan; 25(1):12-20. PubMed ID: 19165658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone, progestogens and psychosomatic health of the climacteric woman.
    Bitzer J
    Maturitas; 2009 Apr; 62(4):330-3. PubMed ID: 19091497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone treatment in the climacteric].
    Siegberg R; Pekonen F
    Nord Med; 1993; 108(10):259-62. PubMed ID: 8414944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
    Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [History of the hormonal treatment of climacteric disease symptoms].
    Kopera H
    Wien Med Wochenschr; 1991; 141(15):346-8. PubMed ID: 1949836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaginal estradiol and progesterone in climacteric therapy].
    Pedersen OD; Jensen HK
    Ugeskr Laeger; 1989 Aug; 151(32):2016-9. PubMed ID: 2672496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and present state of hormone replacement therapy.
    Kopera H; van Keep PA
    Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):412-7. PubMed ID: 1748541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norethindrone--a review of therapeutic applications.
    Taitel HF; Kafrissen ME
    Int J Fertil Menopausal Stud; 1995; 40(4):207-23. PubMed ID: 8520623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
    Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
    Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Principles of hormone substitution in the postmenopause period].
    Keller PJ
    Schweiz Rundsch Med Prax; 1991 Apr; 80(16):431-4. PubMed ID: 2038641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mydocalm treatment of muscular and vascular complaints accompanying climacterics.
    Sásdi A
    Ther Hung; 1992; 40(2):83-5. PubMed ID: 1462282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of hormone substitution therapy on AT III in women in the climacteric].
    Enzelsberger H; Heytmanek H; Kurz C; Metka M
    Zentralbl Gynakol; 1991; 113(11):639-44. PubMed ID: 1656654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.